SAT-737 Low-Dose Testosterone Augmentation for Treatment-Resistant Depression in Women: An 8-Week, Two-Site, Randomized, Placebo-Controlled Study

Objective: Nonresponse to selective serotonin reuptake inhibitor and serotonin norepinephrine reuptake inhibitor treatment is common in patients with major depressive disorder (MDD), particularly in women, occurring in about 70% of patients despite adequate dosing. Well-tolerated augmentation strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Dichtel, Laura E, Carpenter, Linda L, Nyer, Maren, Mischoulon, David, Kimball, Allison, Deckersbach, Thilo, Dougherty, Darin D, Schoenfeld, David, Fisher, Lauren, Cusin, Cristina, Trinh, Nhi-Ha, Pedrelli, Paola, Yeung, Albert, Farabaugh, Amy, Papakostas, George, Chang, Trina, Chen, Justin, Cassano, Paolo, Rao, Elizabeth M, Brady, Roscoe, Singh, Ravinder J, Tyrka, Audrey R, Price, Lawrence, Fava, Maurizio, Miller, Karen Klahr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Steroid Hormones and Receptors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207466/
http://dx.doi.org/10.1210/jendso/bvaa046.081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207466/
http://dx.doi.org/10.1210/jendso/bvaa046.081

Ejemplares similares